Mupider Nasale (Mupirocin)

Mupirocin blocks the bacterial enzyme isoleucyl‑tRNA synthetase, preventing the attachment of isoleucine to its tRNA. This interruption halts protein synthesis, leading to inhibition of bacterial growth and, at higher concentrations, bacterial cell death.

The prescribed dose of Mupider Nasale is determined by the treating clinician based on the specific indication and patient characteristics. Typical regimens involve applying a measured amount of the spray to each nostril once or twice daily for a defined period.

Safety data for mupirocin in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Mupirocin is distinguished by its potent activity against Gram‑positive bacteria, especially Staphylococcus aureus, including methicillin‑resistant strains. Compared with other topical nasal antibiotics, it offers a low propensity for systemic absorption and a well‑characterised safety profile, though resistance can develop with prolonged use.

Store Mupider Nasale at room temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight. Keep the container tightly closed when not in use to maintain sterility.

Mupider Nasale is applied directly into each nostril using the supplied spray device. The patient should tilt the head slightly forward, insert the tip into the nostril, and press the actuator to deliver the prescribed amount. Avoid blowing the nose immediately after application.

Serious adverse events include allergic reactions such as anaphylaxis, severe contact dermatitis, and rare cases of nasal septum perforation. Any signs of systemic hypersensitivity, persistent ulceration, or unexpected infection should prompt immediate medical evaluation.

Individuals with a known hypersensitivity to mupirocin, other topical antibiotics, or any component of the formulation should avoid using Mupider Nasale. It is also contraindicated in patients with active severe nasal ulceration or perforation until the condition is resolved.